NEW YORK (
) hit a new 52-week low Monday as it is currently trading at $9.03, below its previous 52-week low of $9.05 with 154,093 shares traded as of 2:30 p.m. ET. Average volume has been 347,600 shares over the past 30 days.
Natus Medical has a market cap of $286.7 million and is part of the
industry. Shares are down 32.9% year to date as of the close of trading on Friday.
Natus Medical Incorporated develops, manufactures, and markets neurodiagnostic and newborn care products worldwide. The company has a P/E ratio of 20, above the average health services industry P/E ratio of 19.2 and above the S&P 500 P/E ratio of 17.7.
- Practice your BABY trading strategies and win cash in our stock game.
TheStreet Ratings rates Natus Medical as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and unimpressive growth in net income. You can view the full
or get investment ideas from our